Brief: Pasithea Therapeutics to present results of tolerizing vaccine program at Prestigious International Immunotherapy Conference
18/08/2022 13:15
Aug 18 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS TO PRESENT RESULTS OF TOLERIZING
VACCINE
PROGRAM AT PRESTIGIOUS INTERNATIONAL IMMUNOTHERAPY CONFERENCE
Source text for Eikon: ID:nGNX4CKg5y
Further company coverage: KTTA.O
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement